StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
114
This year
24
Publishing Date
2023 - 05 - 11
2
2023 - 05 - 01
2
2023 - 03 - 22
2
2023 - 03 - 09
2
2023 - 01 - 04
1
2022 - 12 - 12
1
2022 - 12 - 07
1
2022 - 12 - 02
2
2022 - 11 - 25
1
2022 - 11 - 10
3
2022 - 09 - 12
1
2022 - 09 - 06
1
2022 - 08 - 30
1
2022 - 08 - 12
1
2022 - 07 - 28
1
2022 - 07 - 27
1
2022 - 07 - 19
1
2022 - 06 - 17
3
2022 - 06 - 07
1
2022 - 05 - 18
1
2022 - 05 - 17
3
2022 - 05 - 12
4
2022 - 05 - 10
1
2022 - 05 - 06
1
2022 - 04 - 07
3
2022 - 03 - 30
2
2022 - 03 - 17
2
2022 - 03 - 15
2
2022 - 03 - 08
2
2022 - 03 - 07
2
2022 - 03 - 04
1
2022 - 01 - 19
2
2022 - 01 - 13
2
2022 - 01 - 05
2
2022 - 01 - 03
1
2021 - 11 - 10
3
2021 - 11 - 04
2
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 21
1
2021 - 10 - 19
2
2021 - 09 - 20
1
2021 - 09 - 03
1
2021 - 08 - 12
5
2021 - 08 - 02
1
2021 - 07 - 19
1
2021 - 07 - 02
2
2021 - 06 - 29
1
2021 - 06 - 21
1
2021 - 06 - 07
3
2021 - 06 - 02
1
2021 - 05 - 27
1
2021 - 05 - 26
1
2021 - 05 - 17
1
2021 - 05 - 07
1
2021 - 05 - 06
4
2021 - 04 - 28
1
2021 - 04 - 20
1
2021 - 04 - 02
1
2021 - 03 - 30
2
Sector
Health technology
114
Tags
Acne
1
Aesthetic
1
Approval
1
Atopic dermatitis
1
Candidate
1
Care
1
Chinese
1
Conference
7
Defa14
1
Dermatitis
2
Disease
2
Drug
1
Enroll
1
Fibrosis
1
Financial
2
Financial results
4
Fmx114
1
Global
1
Granted
1
Health
1
Immunology
1
Initiated
1
Injection
1
Medical
1
N/a
114
Patent
1
Phase 2b
1
Platform
3
Pos
1
Positive
5
Potential
1
Pre-clinical
3
Preclinical
4
Presentation
16
Report
2
Results
7
S
1
Skin
2
Symposium
1
Therapeutics
21
Treatment
3
Trial
4
Update
2
Vyn201
4
Vyn202
1
Entities
Journey medical corp
4
Vyne therapeutics inc.
114
Symbols
DERM
4
VYNE
114
Exchanges
Nasdaq
114
Crawled Date
2023 - 05 - 11
2
2023 - 05 - 01
2
2023 - 03 - 22
2
2023 - 03 - 09
2
2022 - 12 - 07
1
2022 - 12 - 02
2
2022 - 11 - 25
1
2022 - 11 - 10
3
2022 - 09 - 12
1
2022 - 09 - 06
1
2022 - 08 - 30
1
2022 - 08 - 12
1
2022 - 07 - 28
1
2022 - 07 - 27
1
2022 - 07 - 19
1
2022 - 06 - 17
3
2022 - 06 - 07
1
2022 - 05 - 18
1
2022 - 05 - 17
3
2022 - 05 - 12
4
2022 - 05 - 10
1
2022 - 05 - 06
1
2022 - 04 - 07
3
2022 - 03 - 31
1
2022 - 03 - 30
1
2022 - 03 - 17
2
2022 - 03 - 16
2
2022 - 03 - 09
1
2022 - 03 - 08
1
2022 - 03 - 07
2
2022 - 03 - 04
1
2022 - 01 - 19
2
2022 - 01 - 13
2
2022 - 01 - 05
2
2022 - 01 - 03
1
2021 - 11 - 10
3
2021 - 11 - 04
2
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 21
1
2021 - 10 - 19
2
2021 - 09 - 20
1
2021 - 09 - 03
1
2021 - 08 - 12
5
2021 - 08 - 02
1
2021 - 07 - 19
1
2021 - 07 - 02
2
2021 - 06 - 29
1
2021 - 06 - 21
1
2021 - 06 - 07
3
2021 - 06 - 02
1
2021 - 05 - 27
1
2021 - 05 - 26
1
2021 - 05 - 17
1
2021 - 05 - 07
1
2021 - 05 - 06
4
2021 - 04 - 28
1
2021 - 04 - 20
1
2021 - 04 - 02
1
2021 - 03 - 30
2
Crawled Time
00:00
4
01:00
1
10:00
1
11:00
2
12:00
7
12:20
2
12:30
5
13:00
19
13:15
3
13:20
2
13:30
1
14:00
13
14:20
1
15:00
1
15:15
1
16:00
1
17:00
2
18:00
2
20:00
2
21:00
13
22:00
23
23:00
8
Source
beamforall.com
172
feed.businesswire.com
887
hightideinc.com
176
jaguarhealth.gcs-web.com
189
mdxhealth.com
111
spacfeed.com
11303
velodynelidar.com
233
wodrs.com
258
www.amcnetworks.com
140
www.ameresco.com
145
www.biospace.com
36346
www.blackknightinc.com
264
www.blinkcharging.com
130
www.brainsway.com
208
www.channeladvisor.com
142
www.clinuvel.com
103
www.concentrix.com
348
www.confluent.io
203
www.corelogic.com
397
www.cumulusmedia.com
147
www.duckcreek.com
116
www.emmis.com
159
www.extremenetworks.com
527
www.fatetherapeutics.com
150
www.fda.gov
166
www.globenewswire.com
107644
www.hormelfoods.com
181
www.hubspot.com
1241
www.izea.com
127
www.j2global.com
134
www.levistrauss.com
129
www.limoneira.com
373
www.livenationentertainment.com
579
www.marchex.com
107
www.middleby.com
240
www.myfw.com
132
www.nexstar.tv
183
www.northropgrumman.com
104
www.nxtenergy.com
106
www.oncocyte.com
240
www.ooma.com
455
www.pagerduty.com
160
www.parsons.com
232
www.phunware.com
202
www.prnewswire.com
118053
www.progyny.com
185
www.quotient.com
131
www.realogy.com
164
www.revgroup.com
110
www.rubiconproject.com
150
www.shutterstock.com
133
www.snowflake.com
622
www.steelcase.com
153
www.sutrobio.com
164
www.teekay.com
150
www.veritone.com
155
www.vynetherapeutics.com
114
www.wexinc.com
381
www.whirlpoolcorp.com
207
www.wisekey.com
152
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
source :
Www.vynetherapeutics.com
save search
SEC Filing: Form 4
Published:
2023-07-05
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-13.83%
|
O:
-0.49%
H:
3.72%
C:
3.47%
SEC Filing: Form 4
Published:
2023-06-02
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-42.79%
|
O:
-1.31%
H:
6.64%
C:
0.66%
VYNE Investor Relations Presentation
Published:
2023-05-15
(Crawled : 16:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-51.73%
|
O:
0.14%
H:
6.56%
C:
6.08%
presentation
SEC Filing: Form 10-Q
Published:
2023-05-11
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-41.64%
|
O:
0.0%
H:
12.54%
C:
2.01%
SEC Filing: Form 8-K
Published:
2023-05-11
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-41.64%
|
O:
0.0%
H:
12.54%
C:
2.01%
SEC Filing: Form 8-K
Published:
2023-05-01
(Crawled : 13:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-33.65%
|
O:
0.0%
H:
18.63%
C:
14.83%
VYNE Therapeutics Announces Selection of Development Candidate VYN202, a Potential Best-in-Class Oral Small Molecule BD2-Selective BET Inhibitor for the Treatment of Immuno-Inflammatory Conditions
Published:
2023-05-01
(Crawled : 12:20)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-33.65%
|
O:
0.0%
H:
18.63%
C:
14.83%
vyn202
candidate
treatment
therapeutics
potential
VYNE Investor Relations Presentation
Published:
2023-04-20
(Crawled : 12:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-21.75%
|
O:
-7.17%
H:
9.9%
C:
5.8%
presentation
VYNE Therapeutics Announces Positive Preclinical Data for Inhaled Formulation of VYN201 in an In Vivo Model of Idiopathic Pulmonary Fibrosis
Published:
2023-04-19
(Crawled : 13:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
11.5%
|
O:
7.03%
H:
50.75%
C:
33.13%
vyn201
positive
fibrosis
preclinical
therapeutics
SEC Filing: Form 4
Published:
2023-04-04
(Crawled : 22:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
17.91%
|
O:
-1.01%
H:
6.83%
C:
-2.43%
VYNE Investor Relations Presentation
Published:
2023-03-30
(Crawled : 12:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
34.49%
|
O:
2.5%
H:
13.53%
C:
13.53%
presentation
SEC Filing: Form 4
Published:
2023-03-22
(Crawled : 21:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
28.78%
|
O:
-0.74%
H:
0.37%
C:
-5.95%
VYNE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammation Disease Virtual Conference
Published:
2023-03-22
(Crawled : 13:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
28.78%
|
O:
-0.74%
H:
0.37%
C:
-5.95%
conference
disease
therapeutics
SEC Filing: Form 10-K
Published:
2023-03-14
(Crawled : 22:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
44.81%
|
O:
5.39%
H:
2.71%
C:
-5.12%
VYNE Therapeutics Reports Year-End 2022 Financial Results and Provides Business Update
Published:
2023-03-09
(Crawled : 23:00)
- vynetherapeutics.com
DERM
|
$5.69
14.49%
12.65%
320K
|
|
282.67%
|
O:
-3.33%
H:
6.9%
C:
3.45%
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
14.05%
|
O:
-1.31%
H:
1.32%
C:
-0.66%
therapeutics
financial
update
results
SEC Filing: Form 8-K
Published:
2023-03-09
(Crawled : 22:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
14.05%
|
O:
-1.31%
H:
1.32%
C:
-0.66%
VYNE Investor Relations Presentation
Published:
2023-03-01
(Crawled : 14:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
4.65%
|
O:
-1.05%
H:
0.0%
C:
-9.7%
presentation
SEC Filing: Form 8-K
Published:
2023-02-28
(Crawled : 22:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
4.18%
|
O:
-0.37%
H:
0.97%
C:
-0.08%
VYNE Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference
Published:
2023-02-22
(Crawled : 13:20)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
1.75%
|
O:
-0.29%
H:
1.39%
C:
-0.88%
care
conference
health
therapeutics
VYNE Therapeutics Announces Positive Results from Phase 1a Single and Multiple Ascending Dose Trial for Investigational Novel BET Inhibitor VYN201
Published:
2023-02-15
(Crawled : 14:00)
- vynetherapeutics.com
VYNE
|
$3.39
0.3%
0.29%
30K
|
Health Technology
|
-0.29%
|
O:
2.0%
H:
11.48%
C:
-1.68%
vyn201
trial
therapeutics
positive
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
55%
45%
Top 10 Gainers
ZVSA
|
$2.03
3179.48%
96.95%
330K
|
CHSN
|
$4.89
68.63%
45.9%
5.7M
|
ANY
M
|
$1.72
60.75%
37.79%
26M
|
Technology Services
VCXA
|
News
0 d
|
$15.88
60.57%
37.72%
82K
|
CNET
|
News
|
$1.12
60.0%
37.5%
3.8M
|
Commercial Services
MFH
|
$1.62
37.29%
27.16%
6.5M
|
Technology Services
AIHS
|
$0.4389
37.16%
27.09%
230K
|
Finance
KALA
|
$8.83
36.06%
26.5%
2.7M
|
Health Technology
JNVR
|
$1.53
29.66%
21.33%
2.8M
|
WHLR
4
|
$0.3532
26.14%
20.72%
14M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.